Exploiting tumour metabolism for patient benefit Flashcards
TF chemotherapy can cause metabolic changes.
true
what can metabolic changes due to chemotherapy lead to?
drug induced resistance
TF recurring tumours in patients will be the same as before
FALSE
what is the biggest challenge to generalised therapy?
heterogenicity
how can we see if a tumour is OP or glycolytic
radiolabel lactate and pyruvate and use tracer to ID how they’re being used in cells
what can you target alongside the PI3K pathway to have a more effective tumour response to therapy
RTK inhibitors
how will inhibition of the PI3K pathway target HEF1
can stop its stabilisation which is induced by the PI3K pathway independent of available oxygen
silibinin drug effects
stops glucose uptake
G1 cell cycle arrest
angiogenesis inhibition
inhibiting hexokinases does what?
glycolysis inhibition
drugs that target LDHA inhibit
lactate production
drugs which target MCT1 inhibit?
transport of lactate across membranes
how can we target cancers with unregulated respiration by OXPHOS
target the electron transport chain
what can metformin do to the mitochondria and in cancer therapy
inhibits complex 1 so metabolites cant go through the etc and generate ATP
targets complex I in ETC
What can atovaquone do to ATP
inhibit complex III so ATP cannot be generated
other effects of metformin and atovaquone on tumours?
deoxygenate them
gives radiation therapy better effects
allevate hypoxia